NCT07720349

Brief Summary

The need for better follow-up of AMI patients combined with recent developments in the digital area prompted the Department of Cardiology (HJE) at Oslo University Hospital (OUS) Ullevål, in collaboration with the Department of Digital Health Research (DIG) at OUS to develop a digital solution for long-term follow-up after AMI. The overall goal of the digital solution is to increase knowledge and awareness about important lifestyle measures and CV risk factors in patients who have survived an AMI, and to make it easy for the patients to monitor their own risk factors and attainment of treatment goals during long-term follow-up. Further, the HeartCheck seeks to provide guidance to ensure medication adherence. In this project, we study whether this newly developed app (HeartCheck), through education, regular reminders and easily understandable goals for secondary prevention, can improve risk factor control and drug adherence during long-term follow-up after AMI. A randomized controlled trial (RCT) is the chosen study design, being the gold standard for testing effectiveness of interventions.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
630

participants targeted

Target at P75+ for not_applicable coronary-artery-disease

Timeline
41mo left

Started Apr 2026

Typical duration for not_applicable coronary-artery-disease

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
Apr 2026Dec 2029

Study Start

First participant enrolled

April 1, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 17, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 22, 2026

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Last Updated

July 31, 2026

Status Verified

July 1, 2026

Enrollment Period

2.8 years

First QC Date

July 17, 2026

Last Update Submit

July 30, 2026

Conditions

Keywords

coronary artery diseasesecondary preventiondigital application

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients fulfilling 4 evidence-based goals for risk factor control

    Proportion of patients who fulfills all of the following: 1) BP \<130/80 mmHg, 2) LDL-cholesterol \<1.4 mmol/l, 3) HbA1c \<53mmol/mol, 4) No smoking

    12 months after inclusion in the study

Study Arms (2)

Use of a digital application for follow-up

EXPERIMENTAL

Use of the application "Heart-Check" developed by the researchers

Device: "HeartCheck"

Usual care

NO INTERVENTION

Patients are offered standard followed up by their hospital and GP

Interventions

a digital application developed specifically for patient support during follow-up after acute myocardial infarction or PI for stable coronary artery disease

Use of a digital application for follow-up

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>18 years of age
  • survived a recent (\<30 days) AMI and/or PCI
  • access to a smartphone or tablet
  • signed written informed consent

You may not qualify if:

  • patient does not understand Norwegian
  • patient is unable to comply with the study procedures due to severe comorbidities or high age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Sørlandet Hospital Arendal

Arendal, Norway

RECRUITING

Oslo University Hospital Ullevål

Oslo, Norway

RECRUITING

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Sigrun Halvorsen

    Oslo University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sigrun Halvorsen

CONTACT

Ida O Nilsen

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 17, 2026

First Posted

July 22, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 1, 2029

Last Updated

July 31, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations